1. Home
  2. NXPL vs ABP Comparison

NXPL vs ABP Comparison

Compare NXPL & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextPlat Corp

NXPL

NextPlat Corp

N/A

Current Price

$0.61

Market Cap

15.6M

ML Signal

N/A

ABP

Abpro Holdings Inc

N/A

Current Price

$4.67

Market Cap

12.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NXPL
ABP
Founded
1997
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
12.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NXPL
ABP
Price
$0.61
$4.67
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
179.6K
14.3K
Earning Date
11-13-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$57,151,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.00
52 Week Low
$0.43
$3.78
52 Week High
$1.74
$47.10

Technical Indicators

Market Signals
Indicator
NXPL
ABP
Relative Strength Index (RSI) 52.11 39.99
Support Level $0.53 $3.98
Resistance Level $0.64 $5.09
Average True Range (ATR) 0.06 0.38
MACD 0.01 -0.08
Stochastic Oscillator 61.01 24.52

Price Performance

Historical Comparison
NXPL
ABP

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About ABP Abpro Holdings Inc

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Share on Social Networks: